期刊文献+

苦参碱治疗慢性乙型肝炎疗效观察 被引量:1

Clinical Observation on Matrine in Treatment of Chronic Hepatitis B
下载PDF
导出
摘要 目的 观察苦参碱注射液治疗慢性乙型肝炎的临床效果。 方法 对 76例慢性乙型肝炎患者随机分为治疗组和对照组 ,对照组给予茵栀黄注射液 ,治疗组给予苦参碱注射液 ,两组辅助用药为维生素类。结果  两组对纳差、乏力ALT下降方面疗效相似达 80 % ,对腹胀和肝区痛 ,治疗组分别为 96 %和 87% ,对照组分别为 75 %和 6 2 % ,有显著差异 ,对SB消退和HBeAg阴转率方面 ,治疗组分别为 90 %和 5 1% ,对照组为 5 5 %和 2 8% ,P <0 0 1,两组有显著性差异。 结论 苦参碱注射液治疗慢性乙型肝炎有很好的效果 ,特别对退黄和HBeAg阴转方面尤为显著 。 Objective To observe the clinical efficacy of matrine on the treatment of chronic hepatitis B.Methods Seventy-six patients with chronic hepatitis B were randomly divided into treatment group and control group.Control group were treated with Yinzhihuang and vitamin,treatment group were treated with matrine and vitamin.Results Two groups in aspect of appetite reduction and lack power and ALT reduction,the effective rate was 80%.abdominal distension and ache of liver area,the effective rate were 96% and 87% in the treatment group,in control group were 75% and 62%,they were significant difference.on SB reduction and HBeAg negative-transformed rate were 90% and 51% in the treatment group.That in control group were 55% and 28%(P<0.01), there were significant difference.Conclusion The results show that matrine has very good effect in the treatment of chronic hepatitis B,particularly to SB reduction and HBeAg negative-transformed rate,matrine is worth popularizing and applying.
作者 贾新立
出处 《医药论坛杂志》 2004年第2期25-26,共2页 Journal of Medical Forum
关键词 苦参碱 治疗 慢性乙型肝炎 ALT 乙肝病毒 matrine chronic hepatitis B clinical observation
  • 相关文献

参考文献4

二级参考文献3

共引文献1795

同被引文献18

  • 1黄以群,林珍辉,纪树梅,许正锯,王崇国.干扰素α-2b联合苦参素治疗慢性乙型肝炎的临床研究[J].中华传染病杂志,2004,22(4):259-262. 被引量:15
  • 2拉米夫定临床应用专家组,万谟彬.2004年拉米夫定临床应用专家共识[J].中华传染病杂志,2004,22(4):283-287. 被引量:89
  • 3程书权.慢性肝炎的抗病毒治疗现代研究[J].国外医学(病毒学分册),2004,11(6):179-183. 被引量:4
  • 4袁增,张春梅.胸腺肽、苦参素、干扰素治疗慢性乙型肝炎的疗效观察[J].中国乡村医药,2005,12(4):56-57. 被引量:1
  • 5Brunetto MR,Bonono F.Treatment of chronic hepatitis B:from research to clinical practice via the consensus conferences[J].Curr Pharm Pes,2004,10(17):2063-2075.
  • 6Camma C,Licata A,Cabibbo G,et al.Treatment of hepatitis C:critical appraisal of the evidence[J].Exper Opin Pharmadother,2005,6(3):399-408.
  • 7Leung N.Treatment of chronic hepatitis B:case selection and duration of therapy[J].Journal of Gastroenterol Hepatol,2002,17(4):409-414.
  • 8Han SH.Telbivudine:a new nucleoside analogue for the treatment of chronic hepatitis B[J].Expert Opin Investig Drugs,2005,14(4):511-519.
  • 9Marion PL,Salazar FH,Winiers MA,et al.Potent efficacy of entecavir(BMS-200475) in a duck model of hepatitis B virus replication[J].Antimicrob Agents Chemother,2002,48 (1):82-88.
  • 10Sarfaty L,Thabut D,Zoulim F,et al.Sequential treatment with lamivudine and interferon monotherapy in patients alone:results of a pilot study[J].Hepatology,2001,34(3):573.

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部